The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
91
The investigator will base clinical decisions on A1c and modal day analysis of SMBG.
The investigator will base clinical decisions on A1c, modal day analysis of SMBG and CGM data.
International Diabetes Center
Minneapolis, Minnesota, United States
Evaluate the efficacy of SMBG for clinical decisions related to the management of type 2 diabetes.
Time frame: Three, six and nine months.
Determine the incremental benefit of CGM for clinical decision-making.
Time frame: Three, six and nine months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.